Published in Neuroscience on January 01, 2003
CB2 receptor activation attenuates microcirculatory dysfunction during cerebral ischemic/reperfusion injury. Microvasc Res (2009) 1.38
Cannabinoid CB1 receptor-mediated modulation of evoked dopamine release and of adenylyl cyclase activity in the human neocortex. Br J Pharmacol (2004) 0.90
Pharmacological enhancement of endocannabinoid signaling reduces the cholinergic toxicity of diisopropylfluorophosphate. Neurotoxicology (2008) 0.85
Comparative effects of chlorpyrifos in wild type and cannabinoid Cb1 receptor knockout mice. Toxicol Appl Pharmacol (2011) 0.81
Exogenous and endogenous cannabinoids suppress inhibitory neurotransmission in the human neocortex. Neuropsychopharmacology (2011) 0.81
Quantitative measurement of depolarization-induced anandamide release in human and rat neocortex. Naunyn Schmiedebergs Arch Pharmacol (2003) 0.78
Prejunctional and peripheral effects of the cannabinoid CB(1) receptor inverse agonist rimonabant (SR 141716). Naunyn Schmiedebergs Arch Pharmacol (2008) 0.76
Progress in the understanding of cardiac early afterdepolarizations and torsades de pointes: time to revise current concepts. Cardiovasc Res (2000) 2.35
Surgical and neurological complications in a series of 708 epilepsy surgery procedures. Neurosurgery (1997) 2.00
Clinical relevance of quantified intracranial interictal spike activity in presurgical evaluation of epilepsy. Epilepsia (2000) 1.59
The need for repeat angiography in subarachnoid haemorrhage. Neuroradiology (1998) 1.52
Similarities between early and delayed afterdepolarizations induced by isoproterenol in canine ventricular myocytes. Cardiovasc Res (1997) 1.51
Pterional approach for surgical treatment of olfactory groove meningiomas. Neurosurgery (1989) 1.49
Radical osteoclastic craniectomy in sagittal synostosis. Neurosurgery (1990) 1.46
Preoperative depressive symptoms predict postoperative seizure outcome in temporal and frontal lobe epilepsy. Epilepsy Behav (2009) 1.42
Decreased systemic formation of prostaglandin E and prostacyclin, and unchanged thromboxane formation, in alcoholics during withdrawal as estimated from metabolites in urine. Clin Sci (Lond) (1987) 1.39
Effect of the cannabinoid receptor agonist WIN55212-2 on sympathetic cardiovascular regulation. Br J Pharmacol (1999) 1.37
Surgical pathology of temporal lobe epilepsy. Experience with 216 cases. J Neuropathol Exp Neurol (1993) 1.37
PET and SPECT in epilepsy: a critical review. Epilepsy Behav (2009) 1.25
Subdural and depth electrodes in the presurgical evaluation of epilepsy. Acta Neurochir (Wien) (1994) 1.19
Cannabinoids cause central sympathoexcitation and bradycardia in rabbits. J Pharmacol Exp Ther (2000) 1.18
Characterization of functional domains of mDia1, a link between the small GTPase Rho and the actin cytoskeleton. J Cell Sci (2001) 1.17
Novel anticonvulsant drugs. Pharmacol Ther (2006) 1.14
Gabapentin (Neurontin) as add-on therapy in patients with partial seizures: a double-blind, placebo-controlled study. The International Gabapentin Study Group. Epilepsia (1994) 1.12
MR arthrography: pharmacology, efficacy and safety in clinical trials. Skeletal Radiol (2002) 1.11
Gangliogliomas: clinical, radiological, and histopathological findings in 51 patients. J Neurol Neurosurg Psychiatry (1994) 1.10
Cannabinoid CB1 receptor-mediated inhibition of noradrenaline release in the human and guinea-pig hippocampus. Naunyn Schmiedebergs Arch Pharmacol (1997) 1.09
Cannabinoids inhibit striatonigral GABAergic neurotransmission in the mouse. Neuroscience (2002) 1.03
Pediatric farm injuries involving non-working children injured by a farm work hazard: five priorities for primary prevention. Inj Prev (2005) 0.99
Memantine is neuroprotective in a rat model of pressure-induced retinal ischemia. Invest Ophthalmol Vis Sci (1998) 0.99
Expression of NMDA receptor subunit mRNAs in neurochemically identified projection and interneurons in the human striatum. J Comp Neurol (2000) 0.99
Factors influencing surgical outcome in patients with focal cortical dysplasia. J Neurol Neurosurg Psychiatry (2007) 0.98
Prognostic significance of ictal and interictal epileptiform activity in temporal lobe epilepsy. Epilepsia (1995) 0.97
Ganglioglioma: a detailed histopathological and immunohistochemical analysis of 61 cases. Acta Neuropathol (1994) 0.97
Postural imbalance and falls in PSP correlate with functional pathology of the thalamus. Neurology (2011) 0.96
Early and delayed afterdepolarizations associated with cesium chloride-induced arrhythmias in the dog. J Cardiovasc Pharmacol (1990) 0.96
Thoracoabdominal aortic aneurysm repair: interplay of spinal cord protecting modalities. Eur J Vasc Endovasc Surg (2005) 0.96
Islet-activating protein (pertussis toxin) diminishes alpha 2-adrenoceptor mediated effects on noradrenaline release. Naunyn Schmiedebergs Arch Pharmacol (1985) 0.95
Vasospastic reactions in response to the transsylvian approach. Surg Neurol (1998) 0.95
Intrinsically disordered proteins undergo and assist folding transitions in the proteome. Arch Biochem Biophys (2012) 0.94
Ventricle puncture for external CSF drainage and pressure measurement using a modified puncture needle. Acta Neurochir (Wien) (1988) 0.94
Reconsideration of biallelic inactivation of the VHL tumour suppressor gene in hemangioblastomas of the central nervous system. J Neurol Neurosurg Psychiatry (2001) 0.94
Abnormal origin of the ophthalmic artery from the anterior cerebral artery: neuroradiological and intraoperative findings. Neuroradiology (1989) 0.93
Cortical current density reconstruction of interictal epileptiform activity in temporal lobe epilepsy. Clin Neurophysiol (2001) 0.93
Effect of skin disinfection with octenidine dihydrochloride on insertion site colonization of intravascular catheters. Infection (2002) 0.93
Myoclonus in epilepsy patients with anticonvulsive add-on therapy with pregabalin. Epilepsia (2001) 0.93
The impact of molecular genetic analysis of the VHL gene in patients with haemangioblastomas of the central nervous system. J Neurol Neurosurg Psychiatry (1999) 0.92
Anaplastic ganglioglioma: case report and review of the literature. Neurol Res (1994) 0.91
Ovariectomy and estrogen-induced alterations in myocardial contractility in female rabbits: role of the L-type calcium channel. J Pharmacol Exp Ther (1998) 0.91
Evaluation of the North American Guidelines for Children's Agricultural Tasks using a case series of injuries. Inj Prev (2004) 0.91
Cannabinoid CB1 receptor-mediated modulation of evoked dopamine release and of adenylyl cyclase activity in the human neocortex. Br J Pharmacol (2004) 0.90
Modulation of hippocampal serotonin (5-HT) release by endogenous adenosine. Eur J Pharmacol (1985) 0.90
Modulation of electrically evoked acetylcholine release in cultured rat septal neurones. J Neurochem (2001) 0.89
Effects of riluzole on electrically evoked neurotransmitter release. Br J Pharmacol (2000) 0.89
Mice transgenic for exon 1 of Huntington's disease: properties of cholinergic and dopaminergic pre-synaptic function in the striatum. J Neurochem (2003) 0.89
The slope parameter of concentration-response curves used as a touchstone for the existence of spare receptors. Naunyn Schmiedebergs Arch Pharmacol (1997) 0.88
Differential modulation of K(+)-evoked (3)H-neurotransmitter release from human neocortex by gabapentin and pregabalin. Naunyn Schmiedebergs Arch Pharmacol (2007) 0.88
Computer-assisted stereotactic brain operations by means including computerized axial tomography. Appl Neurophysiol (1978) 0.87
Neuronal loss and gliosis of the amygdaloid nucleus in temporal lobe epilepsy. A quantitative analysis of 70 surgical specimens. Acta Neuropathol (1997) 0.87
The neuroprotective properties of gabapentin-lactam. Graefes Arch Clin Exp Ophthalmol (2001) 0.87
Modulation of K+-evoked [3H]-noradrenaline release from rat and human brain slices by gabapentin: involvement of KATP channels. Naunyn Schmiedebergs Arch Pharmacol (2001) 0.87
Surgical pathology of chronic epileptic seizure disorders: experience with 63 specimens from extratemporal corticectomies, lobectomies and functional hemispherectomies. Acta Neuropathol (1993) 0.87
Changes in NMDA receptor subunit gene expression in the rat brain following withdrawal from forced long-term ethanol intake. Naunyn Schmiedebergs Arch Pharmacol (2000) 0.86
NMDA receptor characterization and subunit expression in rat cultured mesencephalic neurones. Br J Pharmacol (1999) 0.86
Effects of gabapentin on release of gamma-aminobutyric acid from slices of rat neostriatum. Arzneimittelforschung (1993) 0.86
Effects of selective h5-HT1B (SB-216641) and h5-HT1D (BRL-15572) receptor ligands on guinea-pig and human 5-HT auto- and heteroreceptors. Naunyn Schmiedebergs Arch Pharmacol (1997) 0.86
Neuronal electrical high frequency stimulation enhances GABA outflow from human neocortical slices. Neurochem Int (2006) 0.85
Association of class I, II, and III MHC gene products with systemic lupus erythematosus. Results of a Central European multicenter study. Rheumatol Int (1989) 0.85
Isoflurane plus nitrous oxide versus propofol for recording of motor evoked potentials after high frequency repetitive electrical stimulation. Electroencephalogr Clin Neurophysiol (1998) 0.85
Sarcoidosis presenting as an intra- or extra-axial cranial mass: report of two cases. Neuroradiology (1997) 0.85
Subtype determination of soma-dendritic alpha2-autoreceptors in slices of rat locus coeruleus. Naunyn Schmiedebergs Arch Pharmacol (1997) 0.84
Effects of cannabinoids on adrenaline release from adrenal medullary cells. Br J Pharmacol (2001) 0.84
Influence of narcotics on luminance and frequency modulated visual evoked potentials in rats. Doc Ophthalmol (2009) 0.84
Surgical treatment of olfactory groove meningiomas using the pterional approach. Acta Neurochir Suppl (Wien) (1991) 0.84
N-ethylmaleimide (NEM) diminishes alpha 2-adrenoceptor mediated effects on noradrenaline release. Naunyn Schmiedebergs Arch Pharmacol (1986) 0.84
False labelling of dopaminergic terminals in the rabbit caudate nucleus: uptake and release of [3H]-5-hydroxytryptamine. Br J Pharmacol (1986) 0.84
Detection of underlying malignancy in patients with paraneoplastic neurological syndromes: comparison of 18F-FDG PET/CT and contrast-enhanced CT. Eur J Nucl Med Mol Imaging (2013) 0.84
Serotonin (5-HT) enhances hippocampal noradrenaline (NA) release: evidence for facilitatory 5-HT receptors within the CNS. Naunyn Schmiedebergs Arch Pharmacol (1986) 0.83
Up-regulation of D3 dopaminergic receptor mRNA in the core of the nucleus accumbens accompanies the development of seizures in a genetic model of absence-epilepsy in the rat. Brain Res Mol Brain Res (2001) 0.83
Pure word deafness after resection of a tectal plate glioma with preservation of wave V of brain stem auditory evoked potentials. J Neurol Neurosurg Psychiatry (1996) 0.83
Farm health surveillance in the Marshfield Epidemiologic Study Area: a pilot study. J Agric Saf Health (2005) 0.83
Endogenous noradrenaline as modulator of hippocampal serotonin (5-HT)-release. Dual effects of yohimbine, rauwolscine and corynanthine as alpha-adrenoceptor antagonists and 5-HT-receptor agonists. Naunyn Schmiedebergs Arch Pharmacol (1985) 0.83
Safety of single and repetitive focal transcranial magnetic stimuli as assessed by intracranial EEG recordings in patients with partial epilepsy. J Neurol (1999) 0.83
Aseptic loosening of straight- and curved-stem Müller femoral prostheses. Arch Orthop Trauma Surg (1991) 0.83
Failure of tyramine to release neuronal ATP as a cotransmitter of noradrenaline in the guinea-pig vas deferens. Naunyn Schmiedebergs Arch Pharmacol (1996) 0.83
Facilitation of epinephrine-induced afterdepolarizations by class III antiarrhythmic drugs. J Electrocardiol (1997) 0.83
Clinical, radiological, and therapeutic features of pleomorphic xanthoastrocytoma: report of three patients and review of the literature. J Neurol Neurosurg Psychiatry (1996) 0.83
Efficacy and frequency of cerebrospinal fluid drainage in operative management of thoracoabdominal aortic aneurysms. Thorac Cardiovasc Surg (2007) 0.83
Why do some antidepressants promote suicide? Psychopharmacology (Berl) (1986) 0.82
Theophylline relieves headache following lumbar puncture. Placebo-controlled, double-blind pilot study. Klin Wochenschr (1986) 0.82
Effects of antiepileptic drugs on GABA release from rat and human neocortical synaptosomes. Naunyn Schmiedebergs Arch Pharmacol (2011) 0.82
Canine ventricular myocyte beta2-adrenoceptors are not functionally coupled to L-type calcium current. J Cardiovasc Electrophysiol (1999) 0.82
Bremazocine causes sympatho-inhibition and hypotension in rabbits by activating peripheral kappa-receptors. J Cardiovasc Pharmacol (1986) 0.82
Continuous external CSF drainage--a perpetual problem in neurosurgery. Surg Neurol (1998) 0.82
Effects of gabapentin and pregabalin on K+-evoked 3H-GABA and 3H-glutamate release from human neocortical synaptosomes. Naunyn Schmiedebergs Arch Pharmacol (2008) 0.82
The effects of continuous and single-dose radiation on choline uptake in organotypic tissue slice cultures of rabbit hippocampus. Neurol Res (2001) 0.82
Opioid peptides decrease noradrenaline release and blood pressure in the rabbit at peripheral receptors. Naunyn Schmiedebergs Arch Pharmacol (1986) 0.82
Inhibition by ethanol of contractions of rat vas deferens: no evidence for selective blockade of P2X-purinoceptors. Naunyn Schmiedebergs Arch Pharmacol (1993) 0.82
Inhibitory effects of the antiparkinsonian drugs memantine and amantadine on N-methyl-D-aspartate-evoked acetylcholine release in the rabbit caudate nucleus in vitro. J Pharmacol Exp Ther (1992) 0.81
[Impaired cerebral autoregulation in asymptomatic patients with carotid artery stenosis: comparison of acetazolamide-SPECT and transcranial CO(2)-dopplersonography]. Zentralbl Chir (2004) 0.81
Involvement of alpha 2-adrenoceptors in the cardiovascular effects of moxonidine. Eur J Pharmacol (1995) 0.81
Involvement of peripheral presynaptic inhibition in the reduction of sympathetic tone by moxonidine, rilmenidine and UK 14304. Eur J Pharmacol (1995) 0.81